Jolene Mason

799 total citations
16 papers, 678 citations indexed

About

Jolene Mason is a scholar working on Immunology and Allergy, Physiology and Rheumatology. According to data from OpenAlex, Jolene Mason has authored 16 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology and Allergy, 6 papers in Physiology and 4 papers in Rheumatology. Recurrent topics in Jolene Mason's work include Allergic Rhinitis and Sensitization (10 papers), Asthma and respiratory diseases (6 papers) and Respiratory and Cough-Related Research (3 papers). Jolene Mason is often cited by papers focused on Allergic Rhinitis and Sensitization (10 papers), Asthma and respiratory diseases (6 papers) and Respiratory and Cough-Related Research (3 papers). Jolene Mason collaborates with scholars based in United States, United Kingdom and Switzerland. Jolene Mason's co-authors include Robert F. Reynolds, Harold S. Nelson, Craig M. Pratt, Tanya L. Russell, William W. Storms, William F. Schoenwetter, Robert A. Nathan, David I. Bernstein, Harold B. Kaiser and Constantine J. Falliers and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, The American Journal of Cardiology and Annals of the Rheumatic Diseases.

In The Last Decade

Jolene Mason

15 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jolene Mason United States	11	421	370	166	145	131	16	678
Román Valiente Spain	16	388 0.9×	331 0.9×	253 1.5×	103 0.7×	41 0.3×	27	669
W. Stricker United States	11	434 1.0×	821 2.2×	36 0.2×	67 0.5×	652 5.0×	14	1.0k
Ha Nguyen United States	9	114 0.3×	417 1.1×	23 0.1×	64 0.4×	364 2.8×	12	735
Misba Beerahee United Kingdom	12	34 0.1×	209 0.6×	20 0.1×	8 0.1×	164 1.3×	34	405
M Serwońska United States	9	39 0.1×	114 0.3×	17 0.1×	13 0.1×	35 0.3×	14	323
Kelly Weiss United States	9	68 0.2×	153 0.4×	10 0.1×	33 0.2×	53 0.4×	17	340
Iona Donnelly United Kingdom	12	40 0.1×	339 0.9×	17 0.1×	5 0.0×	224 1.7×	16	721
Karen P. Kolbasa United States	12	85 0.2×	144 0.4×	18 0.1×	13 0.1×	77 0.6×	14	413
Audreesh Banerjee United States	9	20 0.0×	347 0.9×	13 0.1×	10 0.1×	209 1.6×	10	595
Marcel E. Van Der Straeten Belgium	10	42 0.1×	257 0.7×	20 0.1×	3 0.0×	192 1.5×	12	451

Countries citing papers authored by Jolene Mason

Since Specialization

Citations

This map shows the geographic impact of Jolene Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jolene Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jolene Mason more than expected).

Fields of papers citing papers by Jolene Mason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jolene Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jolene Mason. The network helps show where Jolene Mason may publish in the future.

Co-authorship network of co-authors of Jolene Mason

This figure shows the co-authorship network connecting the top 25 collaborators of Jolene Mason. A scholar is included among the top collaborators of Jolene Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jolene Mason. Jolene Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Whitty, Paula, M. Eccles, Jeremy Grimshaw, et al.. (2004). Using and developing clinical guidelines.

Nelson, Harold S., Robert F. Reynolds, & Jolene Mason. (2000). Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Annals of Allergy Asthma & Immunology. 84(5). 517–522. 103 indexed citations

Reilly, Margaret C., et al.. (1999). Effect of Fexofenadine HC1 on Quality of Life and Work, Classroom, and Daily Activity Impairment in Patients with Seasonal Allergic Rhinitis. The American Journal of Managed Care. 5. 48 indexed citations

Sussman, Gordon L., et al.. (1999). The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology. 104(1). 100–106. 62 indexed citations

Mason, Jolene, et al.. (1999). The systemic safety of fexofenadine HCl. Clinical & Experimental Allergy. 29(S3). 163–170. 51 indexed citations

Pratt, Craig M., Ashley Brown, David Rampe, et al.. (1999). Cardiovascular safety of fexofenadine HCl. Clinical & Experimental Allergy. 29(S3). 212–216. 44 indexed citations

Pratt, Craig M., et al.. (1999). Cardiovascular Safety of FexofenadineHCl. The American Journal of Cardiology. 83(10). 1451–1454. 68 indexed citations

Nathan, Robert A., Jolene Mason, David I. Bernstein, et al.. (1999). Long-Term Tolerability of Fexofenadine in Healthy Volunteers. Clinical Drug Investigation. 18(4). 317–328. 8 indexed citations

Bronsky, Edwin A., et al.. (1998). Effectiveness and Safety of Fexofenadine, a New Nonsedating H₁-Receptor Antagonist, in the Treatment of Fall Allergies. Allergy and Asthma Proceedings. 19(3). 135–141. 57 indexed citations

10.

Day, James H., et al.. (1997). Onset of Action, Efficacy, and Safety of a Single Dose of Fexofenadine Hydrochloride for Ragweed Allergy Using an Environmental Exposure Unit. Annals of Allergy Asthma & Immunology. 79(6). 533–540. 68 indexed citations

11.

Bernstein, David I., et al.. (1997). Efficacy and Safety of Fexofenadine Hydrochloride for Treatment of Seasonal Allergic Rhinitis. Annals of Allergy Asthma & Immunology. 79(5). 443–448. 105 indexed citations

12.

Bernstein, Daniel, William F. Schoenwetter, R.A. Nathan, William W. Storms, & Jolene Mason. (1996). 1010 Fexofenadine: A new nonsedating antihistamine is effective in the treatment of seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology. 97(1). 435–435. 8 indexed citations

13.

Day, James, et al.. (1996). 1007 Onset of action, efficacy and safety of a single dose of 60 mg and 120 mg fexofenadine HCl for ragweed (RW) allergy using controlled antigen exposure in an environmental exposure unit (EEU). Journal of Allergy and Clinical Immunology. 97(1). 434–434. 3 indexed citations

14.

Falliers, Constantine J., et al.. (1996). 1009 Efficacy and safety of fexofenadine HCl in fall seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology. 97(1). 435–435. 15 indexed citations

15.

Wojtulewski, J. A., Peter Gow, Rodney Grahame, et al.. (1980). Clotrimazole in rheumatoid arthritis.. Annals of the Rheumatic Diseases. 39(5). 469–472. 32 indexed citations

16.

Mason, Jolene, et al.. (1977). A General Practice Assessment of ®Alrheumat (Ketoprofen) in the Treatment of Rheumatic Conditions. International Journal of Clinical Practice. 31(9). 127–134. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact